NCT03425929View on ClinicalTrials.gov

Oxytocin, Trauma Disclosure and Intrusions

PHASE1CompletedINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

June 1, 2016

Primary Completion Date

March 18, 2017

Study Completion Date

March 18, 2017

Conditions
Healthy
Interventions
DRUG

Oxytocin

Intranasal administration, 24 international units (IU) oxytocin.

DRUG

Placebo

The placebo nasal sprays contain identical ingredients except for the peptide itself.

Trial Locations (1)

53105

Department of Psychiatry, University of Bonn, Bonn

All Listed Sponsors
lead

University Hospital, Bonn

OTHER

NCT03425929 - Oxytocin, Trauma Disclosure and Intrusions | Biotech Hunter | Biotech Hunter